All sounds great, but the the price says it all.I got in at 22c, can't remember when that was, but not holding my breathin this company, like many others.But as always dyor.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential